Chronic Arsenic Exposure in Nanomolar Concentrations Accelerates Senescent Phenotypes in vitro by Sabo, Heather M.
University at Albany, State University of New York
Scholars Archive
Biological Sciences Honors College
5-2017
Chronic Arsenic Exposure in Nanomolar
Concentrations Accelerates Senescent Phenotypes
in vitro
Heather M. Sabo
University at Albany, State University of New York
Follow this and additional works at: https://scholarsarchive.library.albany.edu/
honorscollege_biology
Part of the Biology Commons, and the Medicine and Health Sciences Commons
This Honors Thesis is brought to you for free and open access by the Honors College at Scholars Archive. It has been accepted for inclusion in
Biological Sciences by an authorized administrator of Scholars Archive. For more information, please contact scholarsarchive@albany.edu.
Recommended Citation
Sabo, Heather M., "Chronic Arsenic Exposure in Nanomolar Concentrations Accelerates Senescent Phenotypes in vitro" (2017).
Biological Sciences. 1.
https://scholarsarchive.library.albany.edu/honorscollege_biology/1
Chronic Arsenic Exposure in Nanomolar Concentrations Accelerates 
Senescent Phenotypes in vitro 
 
 
 
 
 
 
 
 
 
 
An honors thesis presented to the 
 Department of Biological Sciences 
 University at Albany, State University Of New York 
 in partial fulfillment of the requirements for graduation with 
 Honors in Biological Sciences and graduation from  
The Honors College. 
 
 
 
Heather M. Sabo 
Research Mentor: Juan Andres Melendez Ph. D 
Research Advisor: Melinda Larsen Ph. D 
May 2017 
 
 
 
2 
 
 
Abstract 
 
Arsenic is recognized as an environmental carcinogen, in which over 100 million individuals 
worldwide experience chronic exposure through contaminated drinking water. Arsenic exposure is linked 
to several health conditions, such as cancer, diabetes, skin lesions, immune dysfunction, and 
cardiovascular disease.  Here we test the hypothesis that toxicants, such as arsenic, accelerate the program 
of senescence. Human (IMR-90) primary diploid fibroblasts were chronically exposed to arsenic at 
nanomolar concentrations and the impact on the expression of senescent-associated mRNAs was 
evaluated. IMR-90 cells were exposed either to untreated media or exposed to 130nM and 330nM AsCl3 
supplemented media. RNA samples were extracted weekly from IMR-90 cells and RTPCR was 
conducted. Arsenic-exposed IMR-90 cells displayed increases in all senescence-associated transcripts 
monitored, those include Interleukin-6, Interleukin-8, Interleukin-alpha and the cyclin-dependent kinase 
inhibitor protein P16.  At day 40, post AsCl3 exposure, a near 25-100 fold increase in senescent transcript 
expression was observed.  Thus, there appears to be a direct relationship between the duration of toxicant 
stress, and the increased transcription level of senescent transcripts. Our studies suggest that low dose 
AsCl3 exposure promotes senescent transcript expression and very likely accelerates the senescent 
program that has the penitential of creating a cellular niche that is permissive to disease progression.  
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Introduction: 
Arsenic is a naturally occurring element that is found in several components of earth’s 
atmosphere. It is chemically classified as a metalloid, meaning that it behaves as both a metal and 
nonmetal. When referring to arsenic exposure, it is classified as either organic or inorganic arsenic, which 
refers to the bonding of Carbon and Hydrogen. Inorganic arsenic is commonly found in soil and minerals 
such as copper and lead, and is the primary concern of public health officials. Due to its widespread 
natural occurrence, arsenic cannot be easily filtered from the environment. It becomes toxic when, 
“reacting with oxygen or other molecules present in air, water, soil, or by the action of bacteria that live in 
soil or sediment” (11). This leads into the metabolic pathway of how toxicants are metabolized and are 
affected by reactive oxygen species (ROS).  
There are several ways in which people are exposed to arsenic every day, some of which include 
the foods we eat, drinking water, and the air we breathe. According to the Center of Disease Control, the 
average inorganic arsenic consumption is about 3.5 micrograms per day. Governmental officials have 
approved exposure in drinking water up to 10 parts per billion or 130 nanomolar (11). Upon consumption, 
arsenic is processed and passed though the body and is excreted though urine within several days of 
ingestion. Animal testing has shown that chronic exposure to arsenic’s methyl and dimethyl compounds 
results in damage to the urinary bladder and the kidneys (11). Several medical conditions linked to 
chronic arsenic exposure include, renal and bladder cancer, diabetes mellitus, poor healing skin lesions, 
immune dysfunction and cardiovascular disease (3).  These conditions are also presented in individuals 
with chronic inflammation and or mitochondrial disorders.  
Mitochondrial disorders are characterized as, “genetic defects of the oxidative phosphorylation 
pathway which can affect different organs and tissues” (10). One of the many functions of mitochondria 
are to generate the signaling oxidant H2O2. Several environmental stressors are commonly known to alter 
mitochondrial function, leading to an increase in the production of the reactive oxygen species in the form 
of H2O2. Studies have been done performing acute arsenic exposure on fibroblast cells. Results showed a 
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significant increase in oxidative stress along with increased levels of ROS (12). Conclusive studies have 
been done to establish that the signaling network of mitochondrial derived H2O2 are constitutively 
engaged in senescent cells (10). The phase of senescence can be both protective and destructive towards 
cells.  
Senescence is a protective phase that restricts cell-cycle progression, preventing the spread of 
damage to the next cell generation (2). When cells are exposed to cellular stress early on in life, the 
beneficial effects include tumor suppression and tissue repair. However, as senescent cells accumulate 
with age, the senescence-associated secretory phenotype (SASP) can disrupt tissues and contribute to age-
related pathologies, including cancer (6). Cells exposed to intercellular or extracellular stress such as 
onconogenic reagents will transition cells into senescence. Studies using other environmental toxicants 
have successfully induced premature cellular senescence by promoting intracellular ROS production (13). 
In all cases cellular senescence is accompanied by an increase in several key senescence markers. We 
mainly focus on the soluble signaling factors, interleukins and chemokines. Interleukin-6 is the most 
prominent cytokine of the Senescence-Associated Secretory Phenotype (SASP). IL-6 is associated with 
DNA damage and oncogenic stress induced senescence in both human and mouse fibroblasts (2) (4). Due 
to the fact that IL-6 is directly controlled by persistent DNA damage signaling, it makes it a strong, useful 
target for our experiment. Interleukin-8 in also recognized for its role in the detection of cellular 
inflammation. IL-8 mainly functions as a chemoattractant for neutrophils at sites of inflammation (5). 
Research has been done on the increased production of IL-6 and IL-8 in the presence of oncogenic stress 
(5) (9). IL-1α is a key senescence-associated (SA) proinflammatory cytokine that acts as a critical 
upstream regulator of the SA secretory phenotype, involved in surface cell signaling (9). When under 
cellular stress IL-1α is produced by monocytes and macrophages as a proprotein. These proproteins are 
released in response to cell injury (2) (4) (7).  Additionally, P16 is primarily known for being a tumor 
suppressor gene, and is induced by oncogenic stressors (5) (6). A recent study was done using mice to test 
the importance of the P16 gene and its role in cellular senescence during the process of aging.  
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 In this study, genetically engineered mice designed to express premature aging underwent 
additional genome manipulation. A promoter for the gene P16Ink4A was attached to an apoptotic protein, 
which was designed to only be turned on in the presence of a drug. After genomes were manipulated the 
mice were split into two groups. The mice that did not receive the apoptotic protein inducing drug 
experienced regular side effects of aging, such as muscle atrophy and scoliosis. However, the mice that 
received the drug remained essentially ageless. In this case, ever time the P16 tumor suppressing gene 
was turned on, such as in the program of senescence. The apoptotic protein would then kill the cell, 
leading to a clearing of senescent cells (1). This study confirms the importance of the gene P16 and how 
upregulation of this gene results in health conditions associated with aging. Throughout this experiment, 
IL-6, IL-8, IL-1α, and P16 will be used to test for upregulation in senescent associated secretory 
phenotypes.  
As previously mentioned, senescence can be used as a protective factor towards cells. However, 
due to the senescence-associated secretory phenotype (SASP), inflammation can also be detrimental 
towards cells. Chronic inflammation, is associated with many age-related pathophysiologic processes and 
diseases, “including Alzheimer’s disease, 
diabetes, atherosclerosis, osteoarthritis 
and cancer, among others. In addition, 
chronic inflammation is also associated 
with normal aging” (4). Studies show that 
in normal healthy aging individuals, there 
is a 2–4 fold increase in the levels of pro-
inflammatory mediators such as  IL-6, IL-
8 and tumor necrosis factor (TNF)α in 
individuals 50 years of age or older (4). 
This fold increase is compared to younger 
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healthy individuals. As individuals age, the duration in which they are exposed to several environmental 
toxicants inevitably increases. Part of the human body’s response to stress factors, is the initiation of 
inflammation, as a way to become more equipped to fight the stressor. However, chronic inflammation 
leads to a list of age-related diseases. Interestingly enough, several age-related diseases associated with 
chronic inflammation also correlate with diseases associated with chronic arsenic exposure. This raises an 
important question as to whether-or not aging itself drives chronic inflammation, or if there is something 
else causing chronic inflammation, which in turn drives aging. By studying the inflammatory senescent 
factors listed above, we hope to gain a better understanding of the pathway that connect environmental 
toxicants, chronic inflammation, and cellular senescence in which leads to several age-related diseases.  
Whether arsenic specifically promotes senescence is not known, and our studies will determine 
whether this toxicant has the potential to exacerbate degenerative disease progression by accelerating the 
senescent program.   Our studies indicate that low doses of arsenic can prematurely increase the levels of 
many senescent-associated transcripts that have the potential to exacerbate age-associated chronic 
inflammation.   
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Materials and Methods: 
Materials. Minimum essential medium with Earle’s salts and L-glutamine (MEM), Phosphate 
buffered saline solution (PBS), Penicillin, Streptomycin, TRIzol, Quant-iT OliGreen cDNA quantification 
kit, Platinum SYBR Green, Eva Green, and qPCR Supermix-UDG and GAPDH. Dulbecco’s Modified 
Eagle’s medium (DMEM), Fetal Bovine serum (FBS). Maxima H Minus First Strand cDNA Synthesis 
Kit manufactured by Thermo Scince Molecular Biology. Real time RT-PCR primers were purchased from 
Integrated DNA Technology. All other chemicals were from Fisher Scientific and were of Molecular 
grade or higher in quality. 
 Homo Sapiens (IMR-90) fetal lung diploid fibroblasts Growth conditions for IMR-90 cells are 
briefly described. They are grown on 10mL sterile gamma irradiated tissue cell culture plates. MEM 
media contains, L-glutamine, 10% FBS, and are stored at 37 ̊C in a 21% Oxygen incubator. For the 
arsenic supplemented media, concentrations of 130nM AsCl3 and 330nM AsCl3 were used. This media 
was replaced every two days, and cells were split and samples extracted every four to five days (once a 
week). When performing media change, the plate was washed with 4mL of PBS, and fresh media was 
added. When cells were split, they were always split in a 1:4 fashion. This treatment was administered for 
eight weeks. 
 Real-Time RT-PCR The IMR-90 cells were grown for four to five days in their arsenic-free or 
supplemented (130nM, 300nM) media. RNA was isolated from confluent plates using TRIzol reagent 
according to the manufacturing protocol and quantified with a NanoDrop ND-1000 (Thermo Fisher 
Scientific). cDNA was synthesized using Maxima H Minus First Strand cDNA Synthesis kit according to 
the manufacture’s protocol. cDNA was quantified using qPCR Supermix quantification kit according to 
the manufacture protocol. Total cDNA, 500ng, per reaction was amplified with Platinum SYBR Green 
and Eva Green qPCR SuperMix-UDG kit according to manufacture. A applied Biosystems 7500 Real 
Time PCR System was used to test for the primers IL-6, IL-8, IL-1α, and cyclin-dependent kinase 
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inhibitor protein P16. These human gene-specific primer pairs were designed using IDT-DNA Primer 
Quest, Primer Bank.  
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Results 
IMR-90 fibroblast cells were exposed to chronic low dose arsenic in the form of AsCl3 for forty 
days. The arsenic-supplemented media had an arsenic concentration of 130nM, (equivalent to 10ppb) and 
330nM (equivalent to 25ppb). Once a week cell samples were taken from culture and a PCR was 
conducted testing for the following senescent expressing cytokines; IL-6, IL-8, IL-1α, and cyclin-
dependent kinase inhibitor protein P16 protein. Figure 2. represents the first set of RNAs that were 
extracted after five days of treatment. First, analyzing the upregulation of IL-6, we saw a 3.47 fold change 
in the 130nM treated cells compared to the non-treatment cells, and a 6.21 fold change in the 330nM 
cells. While no other significant differences were observed in the levels of the other senescent transcripts 
monitored.   
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Figure 2. Fibroblastic IMR-90 cells after five days of chronic low dose arsenic exposure. The X-axis 
represents the different treatments; non-treatment cells, cells exposed to 130nM AsCl3 concentration, and 
cells exposed to 330nM AsCl3 concentration. The following cytokines were chosen for transcription level 
analysis; IL-6, IL-8, IL- 1α, and senescent protein P16. Two way ANOVA was used to test for statistical 
significance between the control cells and experimental cells. *** represents statistical significance 
between the control and the IL-6 expressed in the 330nM cells. A P value ≤ 0.001 between the two 
samples was recorded. 
 
Carrying forward with the exposure, we continued to see an increase in the senescent phenotypes 
being produced. Figure 3. displays upregulation in senescence cytokines  after twenty-one days of chronic 
low dose arsenic treatment. As presented in the bar graph below, the levels of IL-8 and P16 were most 
affected. 21-days of AsCl3 exposure increased IL-8 expression by 2.67 and 4.88 fold in response to 
130nM and 330nM doses, respectively.  The cell cycle inhibitor P16 showed a significant 8.54 and 17.25 
increase in transcript levels in response to 130nM and the 330nM AsCl3, respectively.  No differences 
were observed in IL-1α expression at day 21. 
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Figure 3. IMR-90 cells after twenty one days of chronic arsenic exposure. Compared to the non-treatment 
control group, small fold changes were observed for the IL-6 and IL-1α cytokines.  IL-8 and P16 protein 
were most affected.  Statistical significance using two way ANOVA was seen in the increased 
transcription levels of both, IL-8 and protein P16. Two stars (**) represents a P value ≤ 0.01. For the 
three cases where four starts are represented (****) a P value ≤0.0001 was calculated. 
 
Weekly RNA samples were continuously extracted, testing for a constant increase in our selected 
senescent cytokines. Day forty represents the last day of the chronic low-dose arsenic exposure. RNA 
samples were again extracted and our five selected cytokines were tested for an increase in cellular 
transcription levels using PCR. Figure 4. represents the upregulation in SASP molecules observed here. 
Starting with IL-6, the fold change compared to the non-treatment group was 28.83 for the 130nM cells, 
and 19.97 for the 330nM cells. As for IL-8 we continue to see upregulation of 15.36, and 33.35 
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respectively for the 130nM and 330nM. With day forty we see a dramatic increase in IL-1α transcript 
levels. The 130nM and 330nM exposure caused and 88.76 and 76.07 fold induction of IL-1α, 
respectively. Lastly, we looked at the P16 protein which also expressed significant upregulation. The 
130nM cells experienced a 37.83 fold change, and the 330nM experienced a 32.31 fold increase. 
 
 
Figure 4. IMR-90 cells, after forty days of chronic arsenic induced exposure. There was significant 
upregulation in the transcription of our selected cytokines. However, the transcription levels for IL- 1α 
specifically is reaching an outstanding fold change of almost 100 fold, compared to our controlled non-
treatment cells. Significant increase was observed in both the P16 protein, and IL-1α cytokines. 
Regarding the P16 protein, a one star (*) significance was seen between the control and the 130nM cells, 
with a P value ≤ 0.05. The significance between the control and the 330nM cells was represented by a P 
value ≤ 0.05. In regard to the IL-1α, there was a significant increase in transcription seen for both the 
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130nM and 330nM cells. Four stars (****) are used for both to represent a P value ≤0.0001. It is evident 
that toxicant cellular stress induced upon these cells is resulting up increased senescent proteins.   
 Over the 40 day chronic low dose exposure, we observed an increasing trend in all four 
senescence marking cytokines. Cells exposed to both 130nM AsCl3 and 330nM AsCl3, expressed a 
dramatic increase in SASP molecules produced. Figures 5. displays the increasing trend of all four of our 
senescence marking molecules produced by cells exposed to 130nM AsCl3. Figure 6. represents a similar 
concept, except figure 6, represents cells exposed to 330nM AsCl3. 
 
Figure 5. IMR-90 cells exposed to 130nM AsCl3 for 40 days. This graph represent the increase in each of 
our senescent marking cytokines through the duration of our exposure. The Y-axis the fold change of our 
cytokines in experimental cells over control cells. The X-axis represents the three days in which PCR 
tested for upregulated cytokines. Here, n=3 and the error bars are represented by SEM. 
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Figure 6. IMR-90 cells exposed to 330nM AsCl3 for 40 days. This graph represent the increase in each of 
our senescent marking cytokines through the duration of our exposure. The Y-axis the fold change of our 
cytokines in experimental cells over control cells. The X-axis represents the three days in which PCR 
tested for upregulated cytokines. Here, n=3 and the error bars are represented by SEM. 
 
The selected cytokines IL-6, IL-8, IL-1α, and cyclin-dependent kinase inhibitor protein P16 were 
chosen to track the rate and quantity in which cells were becoming senescent. By day five of the 
treatment, a threefold change was observed. As the arsenic exposure continued, the transcription levels of 
senescent proteins also continued to increase. On day twenty one, certain cytokines had reached a fold 
change as high as seventeen. Furthermore, after forty days, a near 100 fold change in transcript levels was 
observed. Thus, there is a direct relationship between the quantity of senescent cytokines expressed 
throughout a cell, and the duration in which they are exposed to the toxicant. 
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In addition, the same treatment was performed using Mus musculus fibroblast cells. When 
performing this experiment, two addition variables were implemented. Two MEF cell lines were used, 
one wild type line, and one knock out line regarding the gene Alkbh8. This gene is known to have an 
effect on the way in which cells can adapt to cellular stress. The second variable of interest was, 
percentage of environmental oxygen during incubation. Due to the strong correlation between ROS and 
cell damage, we wanted to see if decreasing the percentage of available oxygen would decrease the 
amount of ROS produced. Thus, hypothesizing that these cells may have a better adaptive response to the 
arsenic treatment. However, the PCR results for these cells were not conclusive.  
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Discussion 
The purpose of this project was to see how prominent senescence-associated cytokines are 
effected by chronic low-dose arsenic exposure. Further understanding this process and the associated 
metabolic pathways, holds the key to understanding age related diseases. If we are able to deduce the 
molecules that are activating senescent pathways, researchers and heath professionals can further educate 
the public which external toxicants to more specifically stay away from. If we are able to control our 
exposure to certain destructive cellular toxicants, we may become closer to understanding the secrets 
behind several age-related diseases. The end all goal is to achieve prolonged life without diseases 
associated with age, such as, renal failure, cancer, rheumatoid arthritis, dementia, and several other 
diseases previously mentioned. 
Due to its wide spread natural occurrence, arsenic was selected as our toxicant of choice. Both the 
Environmental Protection Agency and the Food and Drug Administration approves arsenic standards in 
drinking water up to 10 parts per billion or 130 nanomolar (11). In this study, over the course of forty 
days, IMR-90 fetal lung fibroblasts were exposed to chronic low-dose arsenic at concentrations of 130nM 
and 330nM. Results show, that in just forty days there was an increase in cellular senescence and SASP 
factors were produced. After five days of arsenic exposure we saw that the only cytokine expressing an 
upregulation was IL-6. Studies using melanoma cells showed that IL-6 inhibits proliferation of early cell 
damage but not advanced-stages (5). Thus, we may be experiencing the same effect here. IL-6 may be the 
initial cytokine indicating cellular inflammation, but as the arsenic exposure continued, the other 
cytokines became more prominent. This same study notes P16 showing an upregulation later on in the 
progression of melanoma due to its predominant role in tumor suppression (5). In addition, results from 
an experiment to test the importance of P16 as a tumor suppressor gene and its role in senescence, 
concluded that the program of senescence activates the P16 gene. This agrees with the data we collected 
at day 21 and day 40 of our exposure. As the arsenic exposure continued and cells became senescent, we 
saw an increasing expression in the P16 protein. Lastly, IL-1α ability to act as a surface receptor, may 
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help explain why at day 40 we saw such a dramatic upregulation. As cells become senescent and SASP 
molecules are released, they signal neighboring cells, further promoting inflammation (6). At day 40, 
PCR displayed a dramatic increase in all four of our senescence marking cytokines. Thus, this leads us to 
think that there were several cells sending out signals to neighboring cell. These signals may have been 
detected and expressed by the upregulation in IL-1α. With that in mind, we question how chronic low 
dose arsenic exposure, (as seen in drinking water) affects the progression of cellular senescence in 
mammals. Throughout the duration of this experiment, a change in senescent phenotypes was observed. 
There was a clear association between quantity of senescent cytokines produced and the duration of 
arsenic exposure.   
Although our results suggest that arsenic induces the senescence program, there is still much 
work to be done.  The rate of cell proliferation was not recorded throughout this experiment. The IMR-90 
cells entered this experiment at passage number eight and were cultured up until passage seventeen. 
Under the microscope, visual observations were made noticing the reduced rate of proliferation around 
week three of exposure. The protocol called for cells to be split 1:4 once a week to maintain optimal 
growth under these conditions. For the first three weeks the non-treatment, 130nM and 330nM cells 
visually looked as if they were proliferating at the same rate. After four days of incubation, all three 10mL 
plates containing the different media concentrations had reached one hundred percent confluency and 
were ready to be split. From this point forward the non-treatment cells continued to proliferate the fastest, 
while the treated cells experienced a reduced growth rate. Before each RNA extraction, the cells should 
have been plated allowing for the rate of proliferation to be calculated. Although (P16) is a strong 
indicator of the qualitative rate at which cells are becoming senescent, unless its level of regulation is 
expressed relative to cell number, we cannot determine the actual number of cells becoming senescent. 
Thus, further testing must be done, carefully recording the rate of cell proliferation in order to obtain 
quantitative data as to the number of senescent cells increasing from week to week. 
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In addition to how the cells in culture were analyzed, changes could also be made to the 
techniques used to run PCR. When RNA samples were tested using PCR, our Actin control, plus our four 
selected cytokines were plated simultaneously using one plate. Therefore, each plate represented an older 
sample of cells. Due to the variability that exists between each plate of PCR reactions. It is hard to 
accurately say that the change in the cytokine transcription levels is solely due to the exposure of chronic 
low- dose arsenic. One way to help control these confounding variables would be to run every PCR plate 
at the same time every day (or on the same day). In addition, instead of plating cells by their age. It would 
be beneficial to organize the plate by primers. Meaning, for one plate we would load eight weeks of RNA 
sample on one plate, and just test one primer at a time. This way we can control some of the inevitable 
variation, and have a more accurate way to quantify the week to week changes that are taking place 
within the cells.  
Overall, our results demonstrate that under these conditions that cellular proliferation decreases 
and that rate of cells becoming senescent is more rapid when cells in vitro are exposed to arsenic as an 
external toxicant. It would be interesting to see if the same results are observed when conducted in vivo, 
using Mus musculus as our experimental species. Due to the level of senescent proteins and other tumor 
suppressor genes present throughout different diseases, we would expect for Mus musculus to develop 
certain age-related diseases if exposed to this same arsenic treatment. A potential effect for mice being 
exposed to arsenic contaminated drinking water, is renal sensitivity and or renal cancer (3). Arsenic is 
detoxified and passed through the kidneys before it is excreted through the bladder (3). However, with 
chronic exposure, a buildup of arsenic and dangerous levels of reactive oxygen species promotes nuclear 
reprogramming (8) (9). Pending discoveries may change the standards in which the Environmental 
Protection Agency and the Food and Drug Administration approve arsenic contaminated drinking water. 
Additional topics of interest include ways in which cellular senescence may be reversed, and or ways in 
which the rate of senescence progression can be delayed.  
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